UNITED STATES
                   SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C. 20549

                               FORM 15

Certification and Notice of Termination of Registration under Section 12(g)
of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports
Under Section 13 and 15(d) of the Securities Exchange Act of 1934.

Commission File Number 333-160649
                       ----------

                             EnzymeBioSystems
     ---------------------------------------------------------------------
            (Exact name of registrant as specified in its charter)

               16773 W Park Drive, Chagrin Falls, Ohio, 44023
     ---------------------------------------------------------------------
     (Address, including zip code, and telephone number, including area
     code, of registrant's principal executive offices)

                      Common Stock, par value $0.001
     ---------------------------------------------------------------------
           (Title of each class of Securities covered by this Form)

                                 None
     ---------------------------------------------------------------------
     (Titles of all other classes of securities for which a duty to file
     reports under Section 13(a) or 15(d) remains)

     Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:


     Rule 12g-4(a)(1)(i)    [X]    Rule 12h-3(b)(1)(i)       [ ]
     Rule 12g-4(a)(1)(ii)   [ ]    Rule 12h-3(b)(1)(ii)      [ ]
     Rule 12g-4(a)(2)(i)    [ ]    Rule 12h-3(b)(2)(i)       [ ]
     Rule 12g-4(a)(2)(ii)   [ ]    Rule 12h-3(b)(2)(ii)      [ ]
                                   Rule 15d-6                [ ]

     Approximate number of holders of record as of the certification or
notice date:   9
              ---

Pursuant to the requirements of the Securities Exchange Act of 1934,
EnzymeBioSystems has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.

                               EnzymeBioSystems

Date:  September 9, 2009       By: /s/ Ashot Martirosyan
       -----------------       -------------------------------
                                       Ashot Martirosyan
                                       Principal Executive Officer


Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934.
The registrant shall file with the Commission three copies of Form 15, one
of which shall be manually signed. It may be signed by an officer of the
registrant, by counsel or by any other duly authorized person.  The name and
title of the person signing the form shall be typed or printed under the
signature.